Navigation Links
Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
Date:3/4/2008

d less time in the doctor's office or hospital are important benefits for these patients," said James A. Bianco, M.D., President and CEO of CTI. "We appreciate the efforts of all the people who made this submission possible, especially the investigators and patients who participated in the clinical trials."

CTI also has an ongoing phase III clinical trial, in conjunction with the Gynecologic Oncology Group (GOG), studying XYOTAX as monthly maintenance treatment in ovarian cancer.

About Lung Cancer

Lung cancer is the most common malignancy worldwide. Non-small cell lung cancer (NSCLC) accounts for 80 percent of all lung cancer cases. Within the population of patients with NSCLC requiring chemotherapy, PS2 patients, which account for approximately 25 percent of this group, are a population with special requirements since they have poor survival with cytotoxic chemotherapy and targeted agents. PS2 patients represent a subgroup of patients who are ambulatory and capable of self-care, but are unable to carry out any work activities, although they are up and about more than 50 percent of waking hours. There are presently no drugs approved to treat PS2 patients with advanced NSCLC.

Lung cancer remains the biggest cancer killer in Europe. The incidence of lung cancer in Europe is more than 13 percent of all cancers, and in 2000 resulted in nearly 350,000 deaths.

About XYOTAX(TM)

XYOTAX(TM) (paclitaxel poliglumex, CT-2103) is an investigational, biologically enhanced, chemotherapeutic that links paclitaxel, the active ingredient in Taxol(R), to a biodegradable polyglutamate polymer, which results in a new chemical entity. When bound to the polymer, the chemotherapy is rendered inactive, potentially sparing normal tissue's exposure to high levels of unbound, active chemotherapy and its associated toxicities. Blood vessels in tumor tissue, unlike blood vessels in normal tissue, are porous to molecules like polyglutamate. Based on precl
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
2. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
3. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
4. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
5. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
6. Ocera Therapeutics, Inc. Completes Enrollment in FHAST1, a Pivotal Phase 3 Clinical Trial in Fistulizing Crohns Disease
7. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
8. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
9. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
10. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
11. Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... KANSAS CITY, Kan. , Sept. 18, 2014 ... ), a pet therapeutics company focused on licensing, ... animals, today announced the full exercise of the ... common stock in connection with the company,s previously ... stock.  All of the shares are being offered ...
(Date:9/18/2014)... 2014  LABSCO, the leading specialty sales ... to hospitals, physician office laboratories and alternate ... agreement with Sysmex America.  This agreement is ... the Sysmex XS-1000 i ™, Sysmex pocH-100 ... Automated Hematology Analyzers. The agreement ...
(Date:9/18/2014)...   MacPractice,s MacPractice MD MU version 5.0 ... which designates that the software is capable of supporting ... 2 Meaningful Use measures required to qualify for funding ... MD MU version 5.0 was certified on June 6, ... the National Coordinator-Authorized Certification Body (ONC-ACB) and is compliant ...
Breaking Medicine Technology:Aratana Therapeutics, Inc. Announces Full Exercise of Underwriters' Option to Purchase Additional Shares 2LABSCO Renews Sysmex Distributorship Agreement 2LABSCO Renews Sysmex Distributorship Agreement 3MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 2MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 3MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 4MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 5
... Nov. 16, 2010 eMix , a new business venture ... of its cloud-based image sharing technology for studies and ... expansion into the European marketplace, starting in Germany, Austria and Switzerland. ... features are: Automated report delivery – Enables a ...
... 2010 Berger & Montague, P.C. and ... for Lead Plaintiff and the Class in ... announced the following:IN THE UNITED STATES DISTRICT ... HEMISPHERX:BIOPHARMA, INC. LITIGATION:CIVIL ACTION NO.  09-CV-5262-PSD:SUMMARY NOTICE ...
Cached Medicine Technology:At RSNA, eMix to Exhibit EMR Delivery, Other New Features 2Summary Notice of Proposed Settlement, Settlement Fairness Hearing, and Motion for Award of Attorneys' Fees and Reimbursement of Litigation Expenses 2Summary Notice of Proposed Settlement, Settlement Fairness Hearing, and Motion for Award of Attorneys' Fees and Reimbursement of Litigation Expenses 3
(Date:9/18/2014)... Alexandria, VA — The Public ... more communities have joined the growing ranks of those ... The decisions bring the number of governmental public health ... the non-profit organization that administers the national public health ... health of the public by advancing the quality and ...
(Date:9/18/2014)... Steven Reinberg HealthDay Reporter , THURSDAY, ... Ebola outbreak in West Africa is starting to spread faster than ... new cases of the deadly viral infection were reported in just ... more than 5,300, with roughly half of those reported in the ... of deaths now tops 2,600. WHO has estimated that as ...
(Date:9/18/2014)... 18, 2014 Companies in the ... dioxide, selling it to downstream industries in either gas, ... dioxide are food and beverage manufacturers. Food producers use ... vegetables or pizzas. The gas is also used as ... compound to carbonate soft drinks, beer and other beverages. ...
(Date:9/18/2014)... exercise is good for you. But new research from ... an added benefit for cancer patients undergoing chemotherapy. , ... found that combining exercise with chemotherapy shrunk tumors more ... professor in the School of Nursing and director of ... the senior author on the study, which appears in ...
(Date:9/18/2014)... 2014 Qualis Health, one of the ... white paper, “Advancing Primary Care through the Patient-Centered ... , Authors Jeff Hummel, MD, MPH and Peggy ... organizations engaged in the work of becoming a Patient-Centered ... bolster PCMH objectives, such as generating and providing useful ...
Breaking Medicine News(10 mins):Health News:Ten More Communities Reaping Benefits of National Accreditation 2Health News:Ten More Communities Reaping Benefits of National Accreditation 3Health News:Ten More Communities Reaping Benefits of National Accreditation 4Health News:New Ebola Cases Top 700 in Just One Week, Officials Report 2Health News:New Ebola Cases Top 700 in Just One Week, Officials Report 3Health News:Carbon Dioxide Production in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Carbon Dioxide Production in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Exercise boosts tumor-fighting ability of chemotherapy, Penn team finds 2Health News:Advancing Primary Care Through PCMH and HIT: New White Paper Connects the Dots 2
... scientific study has backed them up by showing that dating, ... they really are. Researchers at the University of Alberta in ... Victoria, carried out the study. ,As a part ... 700 adolescents between 12 to 19 years of age from ...
... the killing last year of an unarmed man on his ... mandatory breathalyzer tests after such shootings. Sean Bell, a 23-year-old ... girlfriend, died in a hail of 50 bullets hours before ... fire on Bells car outside a topless bar. Two ...
... Kerala Tuesday remained glued to their seats in the assembly ... raging fever that has killed 76 people. ... the day. Our only demand is that the government should ... former chief minister Oommen Chandy, now leader of the United ...
... (IIT), Kharagpur, in West Bengal is the top technology ... which held the position last year, a survey ... Data Quest, a technology magazine in India, and International ... IITs have bagged the top seven positions. IIT-Kharagpur climbed ...
... Research from The University of Arizona Sarver Heart Center ... heart disease. Excessive body weight is associated ... left ventricle, the hearts pumping chamber. Known to physicians ... lead to heart failure and rhythm problems. ...
... from Princess Margaret Hospital (PMH) are using a new ... therapy , takes less than an hour and eliminates ... PMH team combined the expertise of surgeons, radiation medicine ... perform its first procedure. It marked the first time ...
Cached Medicine News:Health News:Dating, Drugs and Sex Make Teens Feel Older Than They are 2Health News:Breathalyzer Tests for Cops Involved in Shootings 2Health News:Kerala Opposition's Unique Protest Over Fever Deaths 2Health News:IIT-Kharagpur the Leading Technology College in India: Survey 2Health News:Interoperative Radiotherapy for Breast Cancer Patients 2
... leads are highly advanced ... to bring ease of ... to you and your ... leads are designed for ...
RV Tracking for 100 % Resynchronization...
O-arm combines the best features of a traditional c-arm with an intra-operative 3D scannerfor unparalleled surgical imaging....
LOGIQ Book XP provides you the next generation performance in a compact platform....
Medicine Products: